Large Life Science Company Reorder, page-12

Fair comment. Remains to be seen if DIASource will be coy making or not, but certainly seems like there have been other missed opportunities, and to what cost is also not likely easy to be measured (heaps, no doubt, but still not sure I'd be willing to give exclusivity... My opinion wavers on that sometimes, as it would be very nice to be rich fast).

At the risk of being a dirty rotten optimist, I feel like the named partners we are working with will prove to be very profitable. IMRA, Cook (assuming they don't get sued beyond survival), Sigma, continued VitD sales, etc.

Hey speaking of questions, does anyone know when GC officially finishes as CEO / last day? Just curiosity, please don't read anything sinister into the question.